الربح قبل الضريبة تغيير تاريخ
AstraZeneca USD 4.81B 894M 2026-06
Bayer EUR 321M 2.67B 2026-06
Essilor EUR 2.64B 196M 2026-06
Fresenius EUR 535M 42M 2026-06
Fresenius Medical Care EUR 383M 43M 2026-06
GlaxoSmithKline GBP 2.68B 532M 2026-06
GRIFOLS EUR 247M 135M 2026-06
Lonza CHF 624M 197M 2024-12
Merck EUR 869M 468M 2026-03
Novartis USD 4.27B 430M 2026-06
Philips EUR 546M 356M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sanofi EUR 837M 1.17B 2026-06
Smith & Nephew USD 469M 70M 2025-12
Sonova Holding CHF 234.3M 159.4M 2025-12
UCB EUR 789M 427M 2025-06